West Opens Manufacturing Facility in Ireland
By

By
West Pharmaceutical Services, a manufacturer of packaging and delivery systems for injectable drugs and healthcare products, has opened a new facility in Waterford, Ireland, a global center of excellence for…

Cambrex To Acquire Halo Pharma for $425 Million
By

By
Cambrex, an East Rutherford, New Jersey-based contract manufacturer of small-molecule active pharmaceutical ingredients (APIs), has agreed to acquire Halo Pharma, a Whippany, New Jersey-headquartered contract development and manufacturing organization (CDMO),…

FDA Issues Warning Letter to Baxter’s Claris Injectables Plant
By

By
The US Food and Drug Administration (FDA) has issued a Warning Letter to Baxter International for its drug-manufacturing facility in Ahmedabad, India over violations of cGMP regulations for finished pharmaceuticals.…

Sangamo Therapeutics To Acquire Biotech TxCell
By

By
Sangamo Therapeutics, a Richmond, California-based biopharmaceutical company, has agreed to acquire TxCell, a Valbonne, France-based biotechnology company developing personalized cellular immunotherapies, for approximately EUR 72 million ($84 million). TxCell is…

FDA Takes Steps to Broaden Access to Generic Abuse-Deterrent Opioid Drugs
By

By
US Food and Drug Administration (FDA) Commissioner Scott Gottlieb has provided an update on the agency’s plans to increase access to abuse-deterrent opioid drugs by facilitating development of generic versions…

Gilead’s Kite Pharma, Gadeta in Cell Therapy Pact
By

By
Kite Pharma, Gilead Sciences’ cell-therapy subsidiary, and Gadeta, an Utrecht, Netherlands-based company developing cancer immunotherapies based on gamma delta T cell receptors (TCRs), have formed a pact to develop gamma delta…

Novartis in $1.1-Billion mAb Mfg Pact with MorphoSys, Galapagos
By

By
Novartis has formed a deal with MorphoSys AG, a Planegg, Germany-based developer of antibodies, and Galapagos NV, a Mechelen, Belgium-based clinical-stage pharmaceutical company, to develop and commercialize their joint investigational,…

AbbVie, Amgen, and UCB Lead Pipeline News
By

By
A roundup of the latest market developments from the pipelines of the pharmaceutical majors, featuring news from AbbVie, Amgen, and UCB. Editor’s Note: This article was updated on a continuous…

Pfizer, Astellas Lead Drug Approval News
By

By
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Pfizer, and Astellas Pharma. Editor’s Note: This article was updated on a continuous basis for news…

Moderna Opens Cell-Therapy Manufacturing Site
By

By
Moderna Therapeutics, a Cambridge, Massachusetts-based biotechnology company focusing on messenger RNA (mRNA) therapeutics, has opened a new manufacturing facility in Norwood, Massachusetts for clinical development of mRNA therapeutics. The 200,000-square-foot…